OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice
Duo Li, Weiran Li, Zheng Peng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Trained immunity: Target for prophylaxis and therapy
Athanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1776-1791
Open Access | Times Cited: 27

Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 11

Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1

Trained immunity inducers in cancer immunotherapy
Yongjun Sui, Jay A. Berzofsky
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Ultrasound nanobubble-based combinational strategies of loaded miR-107-3p and CD133 Ab for anti-PD-L1 and anti-hepatocellular cancer stem cells
C Zhang, Yezi Chen, Jiaxuan Han, et al.
International Journal of Pharmaceutics (2025), pp. 125140-125140
Closed Access

Advancing veterinary vaccines design through trained immunity insights
Xin Wang, Guohua Yu
Frontiers in Veterinary Science (2025) Vol. 11
Open Access

Versatile PLGA‐Based Drug Delivery Systems for Tumor Immunotherapy
Yishu Wang, Xiaoming Hu, Jinghui Wang, et al.
Small Methods (2025)
Closed Access

The potency of hematopoietic stem cell reprogramming for changing immune tone
Andrew W. Daman, Jin‐Gyu Cheong, Laura Berneking, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 197-208
Closed Access | Times Cited: 2

Advances in traditional herbal formulation based nano-vaccine for cancer immunotherapy: Unraveling the enigma of complex tumor environment and multidrug resistance
Yasmeen Saeed, Ruimin Zhong, Zhang‐Hua Sun
International Immunopharmacology (2024) Vol. 132, pp. 111948-111948
Closed Access | Times Cited: 1

SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration
Wei Jiang, Sheng Xu, Ping Li
Current Gene Therapy (2024) Vol. 25, Iss. 2, pp. 157-177
Closed Access

Trained immunity-based vaccines: A vision from the one health initiative
Miriam Angulo, Carlos Angulo
Vaccine (2024) Vol. 43, pp. 126505-126505
Closed Access

Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges
Jéssica Lopes‐Nunes, Paula A. Oliveira, Carla Cruz
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 781-797
Closed Access

Glomerular immune injury promotes anti-tumor activity
Shimrit Avraham, Ben Korin, Jerry Hung-Hao Lo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top